Vitality Biopharma (VBIO) stock price, revenue, and financials

Vitality Biopharma market cap is $38.8 m, and annual revenue was $258.29 k in FY 2019

$38.8 M

VBIO Mkt cap, 08-Oct-2018

$258.3 K

Vitality Biopharma Revenue FY, 2019
Vitality Biopharma Net income (FY, 2019)-13.1 M
Vitality Biopharma EBIT (FY, 2019)-13.2 M
Vitality Biopharma Cash, 31-Mar-20196 M

Vitality Biopharma Income Statement

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

248.3k163.4k102.4k258.3k

Revenue growth, %

(34%)(37%)

Cost of goods sold

149.5k108.3k77.9k

Gross profit

98.9k55.1k24.5k

Gross profit Margin, %

40%34%24%

R&D expense

613.1k894.0k1.9m1.8m

General and administrative expense

2.2m2.6m2.5m3.7m

Operating expense total

2.8m3.5m4.4m13.5m

EBIT

(2.7m)(3.5m)(4.4m)(13.2m)

EBIT margin, %

(1104%)(2125%)(4293%)(5123%)

Interest expense

363.01.0k6.8k

Net Income

(141.3k)(5.2m)(4.3m)(13.1m)

Quarterly

USDQ2, 2017Q3, 2017Q2, 2018

Revenue

45.9k39.7k31.0k

Cost of goods sold

20.9k19.9k17.5k

Gross profit

25.0k19.8k13.5k

Gross profit Margin, %

54%50%44%

R&D expense

129.9k255.3k420.6k

General and administrative expense

706.6k669.6k601.9k

Operating expense total

843.4k931.8k1.0m

EBIT

(818.4k)(912.1k)(1.0m)

EBIT margin, %

(1784%)(2298%)(3282%)

Interest expense

95.064.0

Net Income

(1.1m)(2.5m)(898.5k)

Vitality Biopharma Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

1.4m389.7k95.4k1.2m656.3k6.0m

Accounts Receivable

61.6k30.4k19.2k13.8k19.4k

Inventories

8.5k6.5k

Current Assets

1.4m6.1m

Total Assets

1.4m462.3k134.8k1.2m675.8k6.1m

Accounts Payable

79.9k134.0k244.9k373.7k200.5k22.7k

Current Liabilities

1.5m

Total Liabilities

1.5m1.5m653.0k800.7k353.5k1.1m

Additional Paid-in Capital

8.3m11.2m11.8m18.1m22.3m47.2m

Retained Earnings

(8.3m)(12.4m)(12.5m)(17.7m)(22.0m)(42.2m)

Total Equity

(110.4k)(1.1m)(518.2k)374.4k322.3k5.0m

Financial Leverage

-12.9 x-0.4 x-0.3 x3.1 x2.1 x1.2 x

Vitality Biopharma Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(4.2m)(4.0m)(141.3k)(5.2m)(4.3m)(13.1m)

Depreciation and Amortization

12.3k

Accounts Receivable

(22.1k)31.2k11.2k5.4k4.6k

Inventories

(8.5k)2.0k6.5k

Accounts Payable

107.7k4.1k110.9k158.1k(173.2k)285.9k

Cash From Operating Activities

(2.1m)(2.5m)(1.7m)(1.4m)(2.9m)(3.7m)

Cash From Investing Activities

10.5k141.5k

Cash From Financing Activities

3.1m1.5m1.4m2.4m2.4m8.9m

Quarterly

USDQ1, 2016

Net Income

215.6k

Accounts Receivable

18.3k

Accounts Payable

25.8k

Cash From Operating Activities

(486.4k)

Cash From Financing Activities

1.3m

Interest Paid

68.0

Vitality Biopharma Ratios

USDY, 2019

Revenue/Employee

36.9k

Financial Leverage

1.2 x